HB 2070 revises Missouri law on infectious disease exposure notification for certain workers, especially health care workers and first responders. The bill repeals and replaces section 191.658 and adds a new section, 191.633, to require health care facilities to notify exposed health care workers or law enforcement officers within 48 hours when they become aware of an exposure to specified infectious diseases. It also allows first responders who transported a patient or had contact during transport to request information from the facility about whether the patient later tested positive for one of the listed diseases.
The bill applies to a defined list of infectious diseases, including COVID-19, HIV, hepatitis B and C, tuberculosis, measles, mumps, meningococcal disease, rabies, SARS, diphtheria, pertussis, anthrax, plague, rubella, vaccinia, varicella, novel influenza A, and viral hemorrhagic fevers. It also preserves and supplements existing law by stating that these new notification requirements are in addition to, not in place of, current provisions in sections 191.631 and 191.658. The bill further retains the existing HIV exposure disclosure framework, including procedures for health care practitioners to obtain HIV status information from the Department of Health and Senior Services and a misdemeanor penalty for unlawful disclosure.
In practical terms, the bill would expand and clarify exposure-notification duties for health care facilities and the state health department, while creating a more explicit right for certain emergency personnel to receive exposure information after patient transport or treatment. It would affect hospitals, clinics, other health care facilities, the Department of Health and Senior Services, health care practitioners, law enforcement officers, jail and correctional staff, firefighters, EMTs, paramedics, and other first responders. The measure is primarily procedural and confidentiality-related, rather than creating new disease-control powers.
The available context shows no recorded votes or committee testimony, so there is no documented floor or hearing debate to gauge broad sentiment. Based on the bill’s structure, the apparent policy goal is to improve workplace safety and post-exposure notification for front-line responders and health care personnel. The inclusion of COVID-19 and HIV, along with the confidentiality and misdemeanor provisions, suggests the bill balances notification access with privacy protections.
The main point of potential contention is the scope of disclosure: supporters would likely favor faster and clearer notification for exposed workers, while opponents or privacy advocates may be concerned about patient confidentiality, the breadth of diseases covered, and the administrative burden on facilities and the health department. The bill’s requirement that facilities identify the specific disease and the continued restrictions on further disclosure indicate an effort to limit unnecessary release of sensitive medical information.
HB 2070 would repeal and replace Missouri’s existing infectious disease exposure-notification statute, adding a new section that imposes specific notification duties on health care facilities and preserves the state’s HIV disclosure framework. It would require facilities to notify exposed health care workers and law enforcement officers within 48 hours of becoming aware of certain exposures, allow first responders to request post-transport infection information, and maintain criminal penalties for improper disclosure of HIV-related information. The bill would directly affect statutes in Chapter 191 and the practices of hospitals, clinics, the Department of Health and Senior Services, and emergency and public-safety personnel.
No committee transcripts or votes are available, so there is no direct record of support or opposition in the provided materials. The bill’s design suggests generally favorable treatment toward worker safety and exposure transparency, especially for first responders and health care personnel. At the same time, the inclusion of confidentiality limits and penalties indicates an effort to address privacy concerns and make the measure more acceptable to health care and public-health stakeholders.
The likely areas of contention are patient privacy, the breadth of required disease notifications, and the operational burden on health care facilities. Supporters would likely emphasize the need for timely exposure information for exposed workers and first responders, particularly for serious communicable diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Opponents or cautious stakeholders may question whether the disclosure requirements could expose sensitive patient information, create compliance challenges, or duplicate existing reporting obligations under current law.